Early detection of asymptomatic left ventricular dysfunction and high risk of congestive heart failure in haemodialysis patients is crucial for timely therapeutic intervention and improved survival.
Answers are grounded in this paper and cite their sources.
High CV mortality in haemodialysis patients supports intensified monitoring; leaves open optimal LV dysfunction screening strategies.
Cardiovascular diseases are the leading cause of death in patients on haemodialysis. Cardiovascular mortality rate in these patients is approximately 9% per year, with the highest prevalence of left ventricular hypertrophy, ischemic heart disease and congestive heart failure being the most frequent cardiovascular complications. Risk factors for cardiac failure include hypertension, disturbed lipid metabolism, oxidative stress, microinflammation, hypoalbuminemia, anaemia, hyperhomocysteinemia, and increased concentration of asymmetric dimethylarginine, increased shunt blood flow and secondary hyperparathyroidism. Diagnostic strategy for early detection of patients with increased risk for the development of asymptomatic disturbances of systolic and diastolic left ventricular function should include echocardiografic examination, tests for determining coronary vascular disease, as well as tests of myocardial function (BNP, Nt-proBNP). Early detection of patients with a high risk of congestive heart failure enables timely implementation of adequate therapeutic strategy to provide high survival rate of HD patients.
No takes yet. Share an insight, caveat, or question.
Petrović et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: